HomeEmployersScholarrock
Scholarrock

Scholarrock

lever
39 open positions
Last updated Sep 12, 2026
Remote19%
Hybrid37%
On-site43%
Salary shown78%
Avg. listing100d
This month3 new · 0 closed

Associate Director, Regulatory Strategy

$175k–$225k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

Legal & ComplianceRegulatoryFull-TimeExecutive
See 2 similar>
0 0 0 New 2d ago

Associate Director/Director, Medical Operations

$175k–$255k/year
81
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherAssociateFull-TimeExecutive
See 2 similar>
3 0 0 10d ago

Director, Global Quality Control

$200k–$240k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherQuality ControlFull-TimeExecutive
See 2 similar>
1 0 0 11d ago

Senior Engineer II, Downstream Manufacturing Science & Technology (MSAT)

$110k–$135k/year
70
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDevelopmentManufacturingFull-TimeMid
See 3 similar>
4 0 0 12d ago

Sr. Director, Head of Clinical Quality Assurance

$270k–$300k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherQuality AssuranceSenior
See 2 similar>
4 0 0 17d ago

Senior Manager, Contracts

$155k–$205k/year
81
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

Legal & ComplianceContractsFull-TimeSenior
See 2 similar>
3 0 0 18d ago

Senior Accountant

70
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

Finance & AccountingAccountantFull-TimeSenior
See 2 similar>
3 0 0 25d ago

Senior Manager, Veeva Regulatory & Data

$155k–$195k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

Legal & ComplianceOtherManagerRegulatoryFull-TimeSenior
See 4 similar>
3 0 0 1mo ago

Senior Manager, Veeva Commercial & Data

$155k–$195k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherCommercialFull-TimeSenior
See 2 similar>
4 0 0 1mo ago

Senior Director, Chief Information Security Officer

$245k–$325k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherInformation Security OfficerSenior
See 2 similar>
3 0 0 1mo ago

Director, Research & Development Technology

$200k–$260k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDevelopmentFull-TimeExecutive
See 2 similar>
3 0 0 1mo ago

Senior Manager / Associate Director, HCP Marketing (US)

$155k–$225k/year
81
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherAssociateFull-TimeSenior
See 2 similar>
2 0 0 1mo ago

Director/Sr. Director, Clinical Pharmacology

$225k–$315k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDirectorFull-TimeSenior
See 2 similar>
1 0 0 1mo ago
ScholarrockScholarrock·United StatesUnited States·Cambridge·Remote · United States

Director, Meetings & Events

$200k–$250k/year
87
Highest

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDirectorFull-TimeExecutive
See 2 similar>
1 0 0 1mo ago
ScholarrockScholarrock·United StatesUnited States·Cambridge·Remote · United States

Associate Director/Director, Patient Marketing (US)

$175k–$260k/year
76
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDirectorFull-Time - RemoteExecutive
See 2 similar>
2 0 0 1mo ago
ScholarrockScholarrock·United StatesUnited States·Cambridge·Remote · United States

Regional Director, Rx Onboarding and Care Coordination, East

$200k–$250k/year
76
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherRegional DirectorCare CoordinatorHealthcare Non-ClinicalFull-Time - RemoteLead
See 4 similar>
2 0 0 1mo ago

Senior Associate Scientist I, Bioanalytical Assay Development

$80k–$100k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherDevelopmentFull-TimeSenior
See 2 similar>
1 0 0 1mo ago
ScholarrockScholarrock·United StatesUnited States·Cambridge·Remote · Worldwide

Vice President, Commercial Legal Counsel

$325k–$400k/year
79
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherCommercial Legal CounselFull-TimeExecutive
See 2 similar>
4 0 0 2mo ago

Associate Director/Director, Clinical Operations Compliance

$175k–$225k/year
81
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherClinical OperationsFull-TimeExecutive
See 2 similar>
2 0 0 2mo ago
ScholarrockScholarrock·JapanJapan·Tokyo·Hybrid

Director, Supply Chain Japan

70
High

Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on

OtherSupply ChainFull-TimeExecutive
See 2 similar>
5 0 0 2mo ago